|
FY2025
12 months to Dec 31, 2025
|
FY2024
12 months to Dec 31, 2024
|
FY2023
12 months to Dec 31, 2023
|
FY2022
12 months to Dec 31, 2022
|
FY2021
12 months to Dec 31, 2021
|
|
|---|---|---|---|---|---|
| Revenues | |||||
| Operating expenses: | |||||
| Research and development | |||||
| General and administrative | |||||
| Impairment of long-lived assets | |||||
| Impairment of goodwill and indefinite-lived intangible assets | |||||
| Total operating expenses | |||||
| Loss from operations | |||||
| Interest and other income, net | |||||
| Interest income | |||||
| Other (expense) income, net | |||||
| Loss before income taxes | |||||
| Income tax benefit | |||||
| Net loss attributable to non-controlling interest | |||||
| Net loss | |||||
| Basic net loss per share (in dollars per share) | |||||
| Diluted net loss per share (in dollars per share) | |||||
| Shares used in computing basic net loss per share (in shares) | |||||
| Shares used in computing diluted net loss per share (in shares) |
Loading...
